Healius Limited – Panel Receives Application

The Panel has received an application from Healius Limited (ASX: HLS) (Healius) in relation to its affairs.

Healius is the subject of an off‑market scrip takeover bid made by Australian Clinical Labs Limited (ASX: ACL) (ACL).

Details of the application, as submitted by Healius, are below.

A sitting Panel has not been appointed at this stage and no decision has been made whether to conduct proceedings. The Panel makes no comment on the merits of the application.